Following its acquisition by Supernus Pharmaceuticals, Sage Therapeutics has let go of all of its remaining workforce, which ...

The main pharmacological interventions for palliation of breathlessness would be opioids, ie, oromorph and benzodiazepines ...

The Bronchopulmonary Dysplasia Treatment Market is anticipated to be valued at USD 434.1 million in 2025 and is expected to reach USD 788.2 million by 2035, registering a CAGR of 6.1%. The ...

The Daily Edition will not be published Friday or Monday in observance of July Fourth. Look for it again in your inbox on Tuesday, July 8. Below, check out the roundup of California Healthline’s ...